Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, 1129 Nagaoka Izunokuni-shi, Shizuoka, 410-2295, Japan,
J Gastroenterol. 2014 Feb;49(2):324-31. doi: 10.1007/s00535-013-0782-5. Epub 2013 Mar 12.
The present study aimed to evaluate etiology-based differences in the risk of waiting list mortality, and to compare the current Japanese transplant allocation system with the Child-Turcotte-Pugh (CTP) and the Model for End-Stage Liver Disease (MELD) scoring systems with regard to the risk of waiting list mortality in patients with primary biliary cirrhosis (PBC).
Using data derived from all adult candidates for deceased donor liver transplantation in Japan from 1997 to 2011, we assessed factors associated with waiting list mortality by the Cox proportional hazards model. The waiting list mortality risk of PBC patients was further estimated with adjustment for each scoring system.
Of the 1056 patients meeting the inclusion criteria, 743 were not on the list at the end of study period; waiting list mortality was 58.1 % in this group. In multivariate analysis, increasing age and PBC were significantly associated with an increased risk of waiting list mortality. In comparison with patients with hepatitis C virus (HCV) infection, PBC patients were at 79 % increased risk and had a shorter median survival time by approximately 8 months. The relative hazard of PBC patients was statistically significant with adjustment for CTP score and medical point score, which was the priority for ranking candidates in the Japanese allocation system. However, it lost significance with adjustment for MELD score. Stratification by MELD score indicated a comparable waiting list survival time between patients with PBC and HCV.
PBC patients are at high risk of waiting list mortality in the current allocation system. MELD-based allocation could reduce this risk.
本研究旨在评估病因相关的等待名单死亡率差异,并比较当前日本移植分配系统与 Child-Turcotte-Pugh(CTP)和终末期肝病模型(MELD)评分系统在原发性胆汁性肝硬化(PBC)患者等待名单死亡率方面的风险。
利用 1997 年至 2011 年日本所有成人候选者接受已故供体肝移植的数据,我们通过 Cox 比例风险模型评估了与等待名单死亡率相关的因素。进一步通过调整每个评分系统来评估 PBC 患者的等待名单死亡率风险。
在符合纳入标准的 1056 名患者中,有 743 名在研究期末未在名单上;该组的等待名单死亡率为 58.1%。多变量分析显示,年龄增加和 PBC 与等待名单死亡率增加显著相关。与丙型肝炎病毒(HCV)感染患者相比,PBC 患者的风险增加了 79%,中位生存时间缩短了约 8 个月。在调整 CTP 评分和医疗点评分后,PBC 患者的相对危险度具有统计学意义,这是日本分配系统中优先考虑候选者的标准。然而,在调整 MELD 评分后,其意义丧失。MELD 评分分层表明,PBC 患者与 HCV 患者的等待名单生存时间相当。
在当前的分配系统中,PBC 患者等待名单死亡率较高。基于 MELD 的分配可以降低这种风险。